I also serve as an assistant professor of Orthopaedics at The Ohio State University College of Medicine, where I’ve received several distinguished teaching honors including being named Educator of the Year in 2012. My clinical interests include bone and soft tissue sarcomas in adults and children, complex limb reconstruction, metabolic bone disease and musculoskeletal infections.
In my work to find treatments for these types of cancers, I’ve co-authored medical articles on surgical oncology and soft tissue sarcomas, presented nearly three dozen medical abstracts worldwide and have contributed to 45 published manuscripts. Additionally, I serve on the American Board of Orthopedic Surgery and as a fellow with the American Academy of Orthopaedic Surgeons and the American College of Surgeons.
I’m honored to partner with an extraordinary team of leaders who have a steadfast desire to create a cancer-free world.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016
Northeastern Ohio Universities College of Medicine
Summa Health System
7/1/2004 - 7/31/2008
Specialties and conditions I treat
- Orthopaedic Oncology
- Orthopaedic Surgery
- Orthopaedic Surgery – Spine
- Bone Cancer
- Limb Salvage
- Bone Cysts
- Bone Cysts, Aneurysmal
- Exostoses, Multiple Hereditary
- Sarcoma, Kaposi
Locations where I practice
More about my work
University of Washington Medical Ctr
7/1/2008 - 5/31/2009
Texas Health Presbyterian Hospital
1/14/2013 - 4/12/2013
American Board of Orthopaedic Surgery
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Scharschmidt has reported no financial relationships with medical device, research and/or drug companies.